ARTICLE

Evergreen Advisors Serves as Exclusive Financial Advisor to EMINENT Services Corporation

Evergreen Advisors Capital - EMINENT Deal

Evergreen Advisors Capital is pleased to announce its role as the exclusive financial advisor to EMINENT Services Corporation on its sale to CIAN Diagnostics. This collaboration has led to the launch of EMINENT Life Sciences, a new entity focused on delivering cutting-edge solutions to empower clinical trial investigators. 

EMINENT Life Sciences aims to streamline the clinical trial process and enhance the quality of care provided to patients and clinical trial subjects. By combining the expertise of CIAN Diagnostics and EMINENT Services Corporation, the team offers a comprehensive suite of services, including contract development and manufacturing, clinical trial logistics, regulatory compliance, laboratory solutions, and customized clinical trial data analytics.

“We are thrilled to have advised EMINENT Services Corporation on this transformative transaction,” said Justin Horsman, Director at Evergreen Advisors. “This deal represents a perfect synergy between two industry leaders and positions EMINENT Life Sciences to make a significant impact in the clinical diagnostics landscape.” 

Clinical trial investigators benefit significantly from the services offered by EMINENT Life Sciences. The combined companies offer advanced technologies that seamlessly integrate advanced CLIA and CAP-certified clinical laboratory capabilities, state-of-the-art biorepository facilities, FDA-registered logistics expertise, and top-tier CRO support services. This best-in-class team enables investigators, researchers, contract research organizations, university systems, and government agencies to gain access to a one-stop solution for their needs, streamlining the research process and accelerating time-to-market for new discoveries and innovations. 

EMINENT Life Sciences is poised to reshape the landscape of clinical trials by addressing critical challenges faced by the industry. “EMINENT Life Sciences delivers more than 30 years of combined experience in support to large-scale clinical trials,” said Anbu Devasahayam, President, EMINENT Services Corporation. “Joining forces with CIAN Diagnostics gives EMINENT Services Corporation the added benefit of providing companion diagnostics, central laboratory services, and precision diagnostics important for delivering quality clinical trial data to investigators.”

About Evergreen Advisors Capital
Evergreen Advisors Capital, LLC is a leading investment banking and corporate advisory firm focused on assisting emerging growth and middle-market companies in the areas of corporate finance, growth and exit strategies, valuations, and advisory services.

Securities transactions conducted through Evergreen Advisors Capital/Member FINRA/SIPC